4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-16-090656
Options or other derivatives
- Chief Operating Officer acquired 939,948 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| TAYTON-MARTIN HELEN KATRINA Chief Operating Officer | 2016-01-18 | Grant or award · Option to purchase Ordinary Shares | +939,948 | 939,948 | D | ||
Loading xslF345X03/a4.xml…